Bioceres Crop Solutions (NASDAQ:BIOX) Given New $12.00 Price Target at Oppenheimer

Bioceres Crop Solutions (NASDAQ:BIOX) had its price target decreased by Oppenheimer from $13.00 to $12.00 in a research report released on Tuesday,Benzinga reports. Oppenheimer currently has an outperform rating on the stock.

Separately, Canaccord Genuity Group dropped their target price on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Four equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $11.88.

Bioceres Crop Solutions Stock Down 1.7 %

Shares of NASDAQ BIOX opened at $6.87 on Tuesday. Bioceres Crop Solutions has a 1 year low of $5.71 and a 1 year high of $14.05. The firm has a market cap of $430.82 million, a price-to-earnings ratio of 343.67 and a beta of 0.56. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.87 and a current ratio of 1.27. The stock’s 50-day simple moving average is $6.65 and its 200-day simple moving average is $8.07.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its earnings results on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. The business had revenue of $92.60 million for the quarter, compared to analysts’ expectations of $117.15 million. During the same period in the previous year, the firm posted ($0.07) earnings per share. As a group, equities analysts anticipate that Bioceres Crop Solutions will post 0.12 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Bioceres Crop Solutions

A number of hedge funds have recently bought and sold shares of the company. Fourth Sail Capital LP grew its stake in Bioceres Crop Solutions by 61.6% in the third quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company’s stock worth $24,957,000 after purchasing an additional 1,209,277 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Bioceres Crop Solutions by 49.3% during the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock valued at $708,000 after purchasing an additional 29,693 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Bioceres Crop Solutions by 9.5% during the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after purchasing an additional 5,341 shares during the last quarter. Ping Capital Management Inc. grew its holdings in shares of Bioceres Crop Solutions by 7.3% during the fourth quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock valued at $268,000 after purchasing an additional 3,000 shares during the last quarter. Finally, Stifel Financial Corp grew its holdings in shares of Bioceres Crop Solutions by 33.4% during the third quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock valued at $321,000 after purchasing an additional 10,224 shares during the last quarter. 17.68% of the stock is currently owned by institutional investors and hedge funds.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.